ChartMill is a comprehensive online stock research platform designed to empower traders and investors with advanced tools for technical and fundamental analysis. The company provides a robust stock screener that allows users to filter thousands of stocks across major exchanges like NYSE, NASDAQ, and EURONEXT, using over 180 customizable technical and fundamental parameters to identify trading opportunities.
Monday.com (MNDY) combines strong revenue growth, a debt-free balance sheet, and a promising technical setup, signaling a potential breakout stock for investors.
Discover The Bancorp (TBBK), a fintech stock with strong revenue & EPS growth, trading at a reasonable forward P/E of 9.42. A compelling affordable growth opportunity.
Sterling Infrastructure (STRL) shows strong earnings growth, rising profit margins, and a bullish technical chart, making it a top high-growth momentum stock to watch.
Discover RPM International, a reliable dividend stock with strong financial health, consistent growth, and sustainable payouts for long-term investors.
Discover how QUALCOMM (QCOM) aligns with Peter Lynch's GARP strategy, offering strong earnings growth, a low PEG ratio, and solid financial health for long-term investors.
Universal Display Corp (OLED) is a strong growth stock with excellent financial health, high profitability, and a positive technical setup indicating a potential price rise.
Avadel Pharmaceuticals (AVDL) meets the Mark Minervini Trend Template with a strong technical uptrend and accelerating earnings and sales growth momentum.
CIG.C is a quality stock for long-term investors. It shows strong profitability, high cash flow conversion, and an attractive valuation, fitting a disciplined buy-and-hold strategy.
Everus Construction Group (ECG) stock exemplifies the Minervini Trend Template, showing a strong uptrend, trading near 52-week highs, and backed by accelerating earnings and sales growth.
YETI Holdings aligns with Peter Lynch's GARP strategy, showing sustainable earnings growth, strong profitability, and a reasonable stock price for long-term value.
Zebra Technologies (ZBRA) presents a compelling value investment opportunity with strong valuation metrics, solid profitability, and positive growth momentum.
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Wednesday. Discover the stocks that are generating the highest trading volume and driving market activity.
Get a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Stay tuned for the market movements in the S&P500 index on Wednesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
SmartRent's Q3 2025 shows a strategic shift to SaaS, with revenue down but profitability up. The company beat EPS estimates, cut losses, and grew recurring revenue.
Sonos Q4 FY2025 earnings show revenue beat estimates but posted a wider loss per share. Shares rose on the mixed results as the company focuses on its transformation.
XPEL Q3 2025 earnings show strong revenue beat and 11% growth, but EPS missed estimates. Stock rose on positive outlook and a major new profit growth initiative.
GCM Grosvenor (GCMG) Q3 2025 earnings beat analyst estimates for EPS and revenue. The alternative asset manager also reported strong year-to-date growth in fundraising and net income.
Centuri Holdings posts record Q3 2025 revenue but misses on earnings per share. The company also announced a strong backlog and completed its separation from Southwest Gas.
Atlanta Braves Holdings Q3 2025: Earnings beat estimates by 100% despite a slight revenue miss. Strong profit growth driven by cost control and mixed-use development.
MannKind (MNKD) Q3 2025 results beat revenue and EPS estimates. The biopharma's shares rose on strong performance and strategic updates, including the scPharmaceuticals acquisition.
Suncor Energy offers a reliable 4.10% dividend yield, backed by a 10+ year payment history, strong profitability, and a healthy balance sheet with low debt.
Johnson Controls (JCI) beat Q4 earnings and revenue estimates, driving its stock up. The company also issued its strongest earnings growth forecast in over five years.
DigitalOcean Q3 2025 earnings beat EPS estimates, with strong cash flow and positive guidance. Stock rose 8.4% as growth in large customers and AI platform gains investor confidence.
Anika Therapeutics (ANIK) beat Q3 2025 earnings estimates with a profit of $0.04 per share, driving its stock up over 10% despite a slight revenue miss.
Green Plains (GPRE) Q3 2025 earnings beat EPS estimates despite a revenue miss. The stock rose on strategic moves, including debt reduction and progress in its carbon capture initiatives.
ScottsMiracle-Gro's Q4 earnings beat estimates, driven by strong profitability and cost controls. The company's 2026 outlook projects continued growth and margin expansion.
Vera Therapeutics posts Q3 2025 financial results with a widened loss, but key clinical progress for atacicept in IgAN and an upcoming BLA submission drive investor focus.
EyePoint Pharmaceuticals stock falls after Q3 2025 earnings miss estimates. Despite the financial setback, its key DURAVYU trials for wet AMD are fully enrolled and on track for 2026 data.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Turning Point Brands (TPB) Q3 2025 results beat estimates, driven by explosive 628% growth in its Modern Oral category. Shares surged over 11% pre-market.
Acacia Research (ACTG) smashed Q3 2025 revenue estimates by 53% and posted a smaller-than-expected loss, sending shares up nearly 10% in pre-market trading.
Geron's Q3 2025 results show mixed performance, with RYTELO revenue up 67% year-over-year but missing analyst sales estimates, causing a negative market reaction.
Rollins exemplifies quality investing with strong revenue growth, exceptional 125% ROIC, and a capital-light business model in the essential pest control industry.
